Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 283

Sort by

Sort Order Select

Journal Articles

Modified Delphi panel consensus recommendations for management of severe aplastic anemia

Daria V. Babushok, Amy E. DeZern, Carlos M. de Castro, Zora R. Rogers, David Beenhouwer, Michael S. Broder, Suzanne R. Fanning, Sarah N. Gibbs, Rabi Hanna, Jaroslaw P. Maciejewski, Bart L. Scott, Srinivas K. Tantravahi, Marcin W. Wlodarski, Irina Yermilov, Bhumika J. Patel

Blood Adv (2024) 8 (15): 3946–3960.

https://doi.org/10.1182/bloodadvances.2023011642

Published: 2024

Includes: Supplemental data

Journal Articles

Thrombophilia management calculator

Iztok Hozo, Benjamin Djulbegovic

Blood Adv (2024) 8 (15): 3914–3916.

https://doi.org/10.1182/bloodadvances.2024013463

Published: 2024

Includes: Supplemental data

Journal Articles

What's in a name: defining pediatric refractory ITP

Blood Adv bloodadvances.2024012707.

https://doi.org/10.1182/bloodadvances.2024012707

Published: 2024

Journal Articles

Aspiring to equity: race vs ethnicity in clinical research

Nada Hamad

Blood Adv (2024) 8 (14): 3823–3824.

https://doi.org/10.1182/bloodadvances.2024013028

Published: 2024

Journal Articles

A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: An Updated Analysis

Patrick C DeMartino, Meredith B Haag, Aaron B Caughey, Joshua A Roth

Blood Adv bloodadvances.2024013093.

https://doi.org/10.1182/bloodadvances.2024013093

Published: 2024

Includes: Supplemental data

Journal Articles

Healthcare utilization and costs in frail versus non-frail patients with diffuse large B-cell lymphoma

Abi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, Yosuf Kaliwal, Ning Liu, Danielle Nicole Blunt, Shabbir MH Alibhai, Anca Prica, Matthew C Cheung, Lee Mozessohn

Blood Adv bloodadvances.2024013158.

https://doi.org/10.1182/bloodadvances.2024013158

Published: 2024

Includes: Supplemental data

Journal Articles

Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy

Samuel J. Yates, John F. Cursio, Andrew Artz, Keriann Kordas, Michael R. Bishop, Benjamin A. Derman, Satyajit Kosuri, Peter A. Riedell, Justin Kline, Andrzej Jakubowiak, Mylove Mortel, Shalitha Johnson, Mariam T. Nawas

Blood Adv (2024) 8 (14): 3785–3797.

https://doi.org/10.1182/bloodadvances.2024012727

Published: 2024

Journal Articles

Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy

Rick Y. Lin, Anthony D. Anderson, Yoichiro Natori, Mohammed Raja, Michele I. Morris, Antonio Jimenez Jimenez, Amer Beitinjaneh, Trent Wang, Mark Goodman, Lazaros Lekakis, Jay Spiegel, Noa G. Holtzman, Denise Pereira, Cara Benjamin, Akina Natori, Krishna V. Komanduri, Jose F. Camargo

Blood Adv (2024) 8 (14): 3813–3822.

https://doi.org/10.1182/bloodadvances.2024012922

Published: 2024

Includes: Supplemental data

Journal Articles

Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma

Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M Reagan, Umar Farooq, Jason T. Romancik, Timothy McDonnell, Shaun Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E. Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S. Nowakowski, Matthew J Maurer

Blood Adv bloodadvances.2024012838.

https://doi.org/10.1182/bloodadvances.2024012838

Published: 2024

Includes: Supplemental data

Journal Articles

Gaps during pediatric to adult care transfer escalate acute resource utilization in sickle cell disease

Kristen E. Howell, Mariam Kayle, Matthew P. Smeltzer, Vikki G. Nolan, Joacy G. Mathias, Marquita Nelson, Sheila Anderson, Jerlym S. Porter, Nirmish Shah, Jane S. Hankins

Blood Adv (2024) 8 (14): 3679–3685.

https://doi.org/10.1182/bloodadvances.2023011268

Published: 2024

Includes: Supplemental data

Journal Articles

Bringing global hematology research to the forefront

Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge Cortes

Blood Adv (2024) 8 (14): 3607–3611.

https://doi.org/10.1182/bloodadvances.2023011873

Published: 2024

Journal Articles

Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

Mirian Brink, Francien Huisman, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Arjan Diepstra, Tjeerd J. F. Snijders, Gerwin Huls, Joost S. P. Vermaat, Wouter J. Plattel, Marcel Nijland

Blood Adv (2024) 8 (14): 3619–3628.

https://doi.org/10.1182/bloodadvances.2023012531

Published: 2024

Includes: Supplemental data

Journal Articles

Costs and impact of disease in adults with sickle cell disease: a pilot study

Sophie Lanzkron, Nicole Crook, Joanne Wu, Sarah Hussain, Randall G. Curtis, Derek Robertson, Judith R. Baker, Diane Nugent, Amit Soni, Jonathan C. Roberts, Megan M. Ullman, Julie Kanter, Michael B. Nichol

Blood Adv (2024) 8 (14): 3629–3638.

https://doi.org/10.1182/bloodadvances.2023012477

Published: 2024

Journal Articles

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines

Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt

Blood Adv (2024) 8 (13): 3596–3606.

https://doi.org/10.1182/bloodadvances.2024012931

Published: 2024

Includes: Supplemental data

Journal Articles

The American Society of Hematology Health Equity Compendium: examining health equity across the Blood Journals

Warren B Fingrut, James Troyer, Eddrika Russell, Melanie Milagros Aviles, Sherraine Della-Moretta, Dre'Von Dobson, Zainul Shoyeb Hasanali, Bei Hu, Ajibike Lapite, Pallavi M Pillai, Joseph Schramm, Lynda Villagomez, Phuong Vo, Ruth Wang'ondu, Jennifer C Yui, Angela Christine Weyand

Blood Adv bloodadvances.2024013633.

https://doi.org/10.1182/bloodadvances.2024013633

Published: 2024

Includes: Supplemental data

Journal Articles

Industry payments to American Society of Hematology Clinical Practice Guideline authors

Jeremy W. Jacobs, Garrett S. Booth, Laura D. Stephens, Brian D. Adkins, Amarilis A. Martin, George D. Lundberg, Raeshun T. Glover, Shazia S. Khan, Julie K. Silver, Jennifer S. Woo

Blood Adv (2024) 8 (13): 3549–3552.

https://doi.org/10.1182/bloodadvances.2023012527

Published: 2024

Includes: Supplemental data

Journal Articles

ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists

Menaka Pai, Michael Byrne, Adam Cuker, Benjamin Djulbegovic, Jim George, Matthew Seftel, Deirdra R. Terrell, Robert Kunkle, Matthew C. Cheung

Blood Adv (2024) 8 (13): 3553–3554.

https://doi.org/10.1182/bloodadvances.2024013293

Published: 2024

Includes: Supplemental data

Journal Articles

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

Blood Adv (2024) 8 (13): 3497–3506.

https://doi.org/10.1182/bloodadvances.2023012469

Published: 2024

Includes: Supplemental data

Journal Articles

“Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes

Sachin Vadgama, Marcelo C. Pasquini, Richard T. Maziarz, Zhen-Huan Hu, Markqayne Ray, Harry Smith, Ash Bullement, Mark Edmondson-Jones, Will Sullivan, Guillaume Cartron

Blood Adv (2024) 8 (13): 3519–3527.

https://doi.org/10.1182/bloodadvances.2023012240

Published: 2024

Includes: Supplemental data

Journal Articles

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

Blood Adv (2024) 8 (13): 3468–3477.

https://doi.org/10.1182/bloodadvances.2024012880

Published: 2024

Includes: Supplemental data

NARROW

Modified Delphi panel consensus recommendations for management of severe aplastic anemia

Thrombophilia management calculator

What's in a name: defining pediatric refractory ITP

Aspiring to equity: race vs ethnicity in clinical research

A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: An Updated Analysis

Healthcare utilization and costs in frail versus non-frail patients with diffuse large B-cell lymphoma

Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy

Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy

Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma

Gaps during pediatric to adult care transfer escalate acute resource utilization in sickle cell disease

Bringing global hematology research to the forefront

Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

Costs and impact of disease in adults with sickle cell disease: a pilot study

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines

The American Society of Hematology Health Equity Compendium: examining health equity across the Blood Journals

Industry payments to American Society of Hematology Clinical Practice Guideline authors

ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

“Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only